PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2019

Nov 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2019-11-04

Reporting Person: BRYCE RICHARD PAUL (SEE REMARKS)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-04	COMMON STOCK	S	88	$7.3801	Disposed	36538	Direct

Footnotes

F1: The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.